Institutional Ownership Silence Therapeutics PLC (SLN)
This table provides information about the institutional ownership of Silence Therapeutics PLC (SLN). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 22.7 Million shares, which have been reported (via 13F filing form) to have a value of $141 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
76,008
shares
|
$472,769
0.0% of portfolio
|
Q1 2025
Reduced 46.49%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
May 12, 2025 Q1 2025 |
71,497
shares
|
$444,711
0.0% of portfolio
|
Q4 2024
Reduced 42.84%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
64,886
shares
|
$403,590
0.0% of portfolio
|
Q1 2025
Reduced 87.0%
|
|
Ubs Oconnor LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
62,639
shares
|
$389,614
0.01% of portfolio
|
Q1 2025
Reduced 51.44%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
62,441
shares
|
$388,383
0.0% of portfolio
|
Q1 2025
Reduced 77.92%
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
61,071
shares
|
$379,861
0.0% of portfolio
|
Q1 2025
Added 0.94%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
49,200
shares
|
$306,024
0.0% of portfolio
|
Q1 2025
Reduced 50.2%
|
|
Shay Capital LLC
New York, NY |
May 15, 2025 Q1 2025 |
47,728
shares
|
$296,868
0.02% of portfolio
|
Q1 2025
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
35,414
shares
|
$220,275
0.0% of portfolio
|
Q1 2025
Added 833.67%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
29,417
shares
|
$182,973
0.0% of portfolio
|
Q2 2024
Added 31.17%
|
|
Jump Financial, LLC
Chicago, IL |
May 14, 2025 Q1 2025 |
26,351
shares
|
$163,903
0.0% of portfolio
|
Q1 2025
New holding
|
|
Virtus Investment Advisers, Inc.
Hartford, CT |
May 14, 2025 Q1 2025 |
24,872
shares
|
$154,703
0.02% of portfolio
|
Q1 2025
New holding
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
24,375
shares
|
$151,612
0.0% of portfolio
|
Q1 2025
Reduced 33.92%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
18,913
shares
|
$117,638
0.0% of portfolio
|
Q1 2025
Reduced 65.45%
|
|
Adar1 Capital Management, LLC
Austin, TX |
May 15, 2025 Q1 2025 |
18,643
shares
|
$115,959
0.01% of portfolio
|
Q1 2025
Added 3.57%
|
|
Rathbones Group PLC
Liverpool, X0 |
May 13, 2025 Q1 2025 |
18,421
shares
|
$114,578
0.0% of portfolio
|
Q2 2024
Reduced 7.46%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
16,032
shares
|
$99,719
0.0% of portfolio
|
Q1 2025
Reduced 97.47%
|
|
Acadian Asset Management LLC
Boston, MA |
May 21, 2025 Q1 2025 |
12,153
shares
|
$75,591
0.0% of portfolio
|
Q1 2025
Reduced 37.57%
|
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
Apr 29, 2025 Q1 2025 |
9,432
shares
|
$58,667
0.0% of portfolio
|
Q1 2025
Reduced 5.33%
|
|
Gamma Investing LLC
Foster City, CA |
Jul 14, 2025 Q2 2025 |
8,333
shares
|
$51,831
0.0% of portfolio
|
Q2 2025
Added 134.07%
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
7,364
shares
|
$45,804
0.0% of portfolio
|
Q1 2025
Reduced 93.07%
|
|
Fny Investment Advisers, LLC
|
Apr 17, 2025 Q1 2025 |
7,000
shares
|
$43,540
0.01% of portfolio
|
Q1 2025
Reduced 60.03%
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
6,854
shares
|
$42,631
0.0% of portfolio
|
Q1 2025
Added 11.88%
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2025 Q1 2025 |
4,263
shares
|
$26,515
0.0% of portfolio
|
Q1 2025
Added 181.39%
|
|
Jones Financial Companies Lllp
|
May 28, 2025 Q1 2025 |
2,500
shares
|
$15,550
0.0% of portfolio
|
Q1 2025
Added 9900.0%
|